semaglutide weight loss creve coeur Physician-led, primary care–based GLP-1 in St. Louis STL Medical Weight Loss |

However, as we discuss, neither compound can be legally sold in the U.S

The median follow-up was only 47 days, too short for most patients to lose enough weight to meaningfully alter their levothyroxine requirements through the weight-based mechanism alone

Mounjaro (tirzepatide) : Mounjaro is an injectable medication approved for the treatment of Type 2 diabetes and increasingly prescribed off-label for weight loss due to its potent dual action on both GLP-1 and GIP receptors

If you are enjoying the podcast, PLEASE click here to leave us a review in iTunes, it will really mean a lot to us

Some clinicians prescribe based on the insulin resistance and metabolic dysfunction itself, but insurance coverage may not follow